TotalMarketCap

Dyne Therapeutics

DYNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.246 B

$17.38 -6.26%

Close of 6 Nov 2026

As of 6 Nov 2026, Dyne Therapeutics (DYN) has a market capitalization of $3.25B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$446.20

Loss-making

Shares outstanding

187,386,963

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #70Viking TherapeuticsVKTX$3.29B
  2. #71Enliven TherapeuticsELVN$3.28B
  3. #72Dyne TherapeuticsDYN$3.25B
  4. #73Viridian TherapeuticsVRDN$3.24B
  5. #74Telix PharmaceuticalsTLX$3.19B

What if Dyne Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$151,204.36

Per share 8,700× higher

Bitcoin $1.53T

$8,181.40

Per share 471× higher

Apple $5.02T

$26,858.79

Per share 1,545× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Dyne Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.